Il y a eu 50 transactions d'initiés récentes enregistrées pour Bio-Techne Corporation (TECH), dont 19 achats et 29 ventes. Le total des achats d'initiés s'élève à $3.39M et le total des ventes d'initiés à $13.82M.
Les initiés notables ayant une activité récente comprennent Crouse Steven C., Herr Amy E., Mcmanus Matthew. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — TECH
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-02 |
Crouse Steven C. |
President - Diag & Spatial Bi |
Attribution de RSU |
735 |
- |
- |
735 |
| 2026-03-01 |
Crouse Steven C. |
President - Diag & Spatial Bi |
Inconnu |
19,151 |
$53.60 |
$1.03M |
- |
| 2026-02-17 |
Herr Amy E. |
Director |
Vente Informative |
1,976 |
$59.11 |
$116.79K |
200 |
| 2026-02-03 |
Herr Amy E. |
Director |
Exercice d'Options (Vente) |
38 |
- |
- |
77 |
| 2026-02-01 |
Mcmanus Matthew |
President - Diag & Spatial Bio |
Exercice d'Options (Vente) |
4,621 |
- |
- |
4,620 |
| 2025-11-03 |
Hippel James |
CFO |
Exercice d'Options (Vente) |
13,159 |
- |
- |
- |
| 2025-11-03 |
Kelderman Kim |
Chief Executive Officer |
Retenue Fiscale RSU |
2,303 |
$62.57 |
$144.1K |
48,665 |
| 2025-11-03 |
Geist William |
President, Protein Sciences |
Exercice d'Options (Vente) |
9,911 |
- |
- |
- |
| 2025-10-30 |
Higgins John L |
Director |
Attribution de RSU |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Baumgartner Robert V |
Director |
Attribution de RSU |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Keegan Joseph D |
Director |
Attribution de RSU |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Bushman Julie L |
Director |
Attribution de RSU |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Vessey Rupert |
Director |
Attribution de RSU |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Seth Alpna |
Director |
Attribution de RSU |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Klimovsky Judith V. |
Director |
Attribution de RSU |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Herr Amy E. |
Director |
Attribution de RSU |
1,640 |
- |
- |
2,680 |
| 2025-08-25 |
Baumgartner Robert V |
Director |
Exercice d'Options (Vente) |
17,040 |
$21.84 |
$372.15K |
- |
| 2025-08-25 |
Nusse Roeland |
Director |
Exercice d'Options (Vente) |
17,040 |
$21.84 |
$372.15K |
- |
| 2025-08-15 |
Hippel James |
CFO |
Exercice d'Options (Vente) |
4,010 |
- |
- |
8,021 |
| 2025-08-15 |
Kelderman Kim |
Chief Executive Officer |
Exercice d'Options (Vente) |
8,543 |
- |
- |
17,087 |
| 2025-08-15 |
Geist William |
President, Protein Sciences |
Exercice d'Options (Vente) |
2,623 |
- |
- |
5,246 |
| 2025-08-15 |
Mcmanus Matthew |
President - Diag & Spatial Bio |
Retenue Fiscale RSU |
880 |
$53.60 |
$47.17K |
4,735 |
| 2025-08-15 |
Bohnen Shane |
SVP - General Counsel |
Exercice d'Options (Vente) |
50 |
- |
- |
49 |
| 2025-08-15 |
Herr Amy E. |
Director |
Exercice d'Options (Vente) |
119 |
- |
- |
118 |
| 2025-08-07 |
Higgins John L |
Director |
Exercice d'Options (Vente) |
5,040 |
$21.84 |
$110.07K |
- |
| 2025-07-29 |
Hippel James |
CFO |
Exercice d'Options (Vente) |
168,620 |
$44.33 |
$7.47M |
- |
| 2025-07-22 |
Kelderman Kim |
Chief Executive Officer |
Exercice d'Options (Vente) |
48,176 |
$44.33 |
$2.14M |
- |
| 2025-07-15 |
Kelderman Kim |
Chief Executive Officer |
Retenue Fiscale RSU |
32,933 |
$51.42 |
$1.69M |
42,203 |
| 2025-06-09 |
Herr Amy E. |
Director |
Exercice d'Options (Vente) |
1,280 |
$44.33 |
$56.74K |
- |
| 2025-05-01 |
Higgins John L |
Director |
Exercice d'Options (Vente) |
12,000 |
$21.84 |
$262.08K |
5,040 |
| 2025-04-03 |
Bohnen Shane |
SVP - General Counsel |
Exercice d'Options (Vente) |
2,260 |
- |
- |
2,259 |
| 2025-02-14 |
Herr Amy E. |
Director |
Exercice d'Options (Vente) |
1,976 |
$44.33 |
$87.6K |
1,280 |
| 2025-02-03 |
Herr Amy E. |
Director |
Attribution de RSU |
115 |
- |
- |
115 |
| 2025-02-01 |
Geist William |
President, Protein Sciences |
Exercice d'Options (Vente) |
3,320 |
- |
- |
- |
| 2025-02-01 |
Mcmanus Matthew |
President - Dgs |
Retenue Fiscale RSU |
1,642 |
$73.55 |
$120.77K |
2,978 |
| 2025-02-01 |
Herr Amy E. |
Director |
Inconnu |
480 |
- |
- |
- |
| 2025-01-27 |
Kelderman Kim |
Chief Executive Officer |
Exercice d'Options (Vente) |
13,392 |
$37.70 |
$504.88K |
- |
| 2024-11-01 |
Hippel James |
CFO |
Exercice d'Options (Vente) |
13,159 |
- |
- |
13,159 |
| 2024-11-01 |
Kelderman Kim |
Chief Executive Officer |
Retenue Fiscale RSU |
2,430 |
$75.31 |
$183K |
39,004 |
| 2024-11-01 |
Geist William |
President, Protein Sciences |
Exercice d'Options (Vente) |
9,912 |
- |
- |
9,911 |
| 2024-10-24 |
Higgins John L |
Director |
Attribution de RSU |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Baumgartner Robert V |
Director |
Attribution de RSU |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Keegan Joseph D |
Director |
Attribution de RSU |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Nusse Roeland |
Director |
Attribution de RSU |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Bushman Julie L |
Director |
Attribution de RSU |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Vessey Rupert |
Director |
Attribution de RSU |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Seth Alpna |
Director |
Attribution de RSU |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Klimovsky Judith V |
Director |
Attribution de RSU |
1,462 |
- |
- |
2,142 |
| 2024-09-12 |
Higgins John L |
Director |
Exercice d'Options (Vente) |
6,000 |
$22.95 |
$137.7K |
- |
| 2024-08-29 |
Kelderman Kim |
Chief Executive Officer |
Exercice d'Options |
1,492 |
$66.97 |
$99.92K |
41,434 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
